A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Conditions: Metastatic Appendiceal Adenocarcinoma; Intraperitoneal Paclitaxel Interventions: Drug: Dexamethasone; Drug: Diphenhydramine; Drug: Famotidine; Drug: Paclitaxel Sponsors: M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Benadryl | Cancer | Cancer & Oncology | Dexamethasone | Famotidine | Research | Study